Register
Login:
Share:
Email Facebook Twitter

RNS VIDEO: Reabold Resources #RBD raise £6 million and take stake in Danube Petroleum Watch here

EXCLUSIVE: HemoGenyx are creating blood cancer treatments with US$9 billion market potential


Astrazeneca Share Chat (AZN)



Share Price: 4,884.50Bid: 4,884.50Ask: 4,886.00Change: 0.00 (0.00%)No Movement on Astrazeneca
Spread: 1.50Spread as %: 0.03%Open: 4,911.00High: 4,945.00Low: 4,883.00Yesterday’s Close: 4,884.50


Share Discussion for Astrazeneca


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


easyp
Posts: 327
Answer
Opinion:Buy
Price:4,935.00
RE: Buy, hold or sell?
Tue 17:54
My modest stack of shares all acquired in the forty something bracket and I believe there will be another bid for AZ. I would expect a share cash deal of £60 ish if the new drug pipeline goes well
 
Keee
Posts: 272
Off Topic
Opinion:No Opinion
Price:4,929.00
RE: Buy, hold or sell?
Tue 11:12
Buy and sell at £52 ;)
easyp
Posts: 327
Question
Opinion:No Opinion
Price:4,879.50
Buy, hold or sell?
Mon 08:08
Any views?
easyp
Posts: 327
Question
Opinion:No Opinion
Price:4,767.00
RE: More good news and selling!!!
2 Dec '17
Is there a concern that Trump might bash the Pharma Industry over drug pricing? Hold a few AZ purchased after the drop to £42 ish earlier this year and had hoped for better given there are some potentially block busting drugs in the pipeline. Not a share I lose sleep over but a little disappointed by the downs and ups.
scooter786
Posts: 31
Off Topic
Opinion:No Opinion
Price:4,910.00
RE: More good news and selling!!!
29 Nov '17
I agree with you mate. All dollar earners have been hammered today.
oldabutnowisa
Posts: 323
Observation
Opinion:Strong Buy
Price:4,963.50
More good news and selling!!!
28 Nov '17
I don't know what this market expects of AZN. Virtually every time it puts out good news (and there has been a LOT lately) price falls. I have enough but reckon they are at least seven pounds too low. If - as I expect- MYSTIC result in 6mths is positive, SP will go back to sixty pounds plus and that will be a fiver or more too low. Any smart Yankee drug co
should be tucking into AZN with their nice expensive $$.
chcscoop11
Posts: 11
Off Topic
Opinion:No Opinion
Price:5,020.00
Updated Broker Rating
16 Nov '17
Reiteration from Jefferies on 5100. Doesn't really say a lot given the SP is only 2% off this level and was up towards 5200 only a few weeks ago. Interestingly however we have a real range from the street with 4 brokers recommending prices in November alone (4340 from HSBC to 5800 from Berenberg.) Question remains which one is accurate and when will the recovery back to 5500 come?
Hugh-Jarse
Posts: 1,336
Off Topic
Opinion:No Opinion
Price:4,959.50
RNS 14/15Nov 2017.....
15 Nov '17
oldabutnowisa
Posts: 323
Observation
Opinion:Strong Buy
Price:4,962.00
Good 3rd Q statement
9 Nov '17
Released on bad day in market which is very equivocal about AZN, Patience!!!
oldabutnowisa
Posts: 323
Observation
Opinion:Strong Buy
Price:5,024.00
So much for my last posting!
7 Nov '17
Chart now gone to pot again!!! When (not if, note) I am proved right in May, there will be a whole load of sad people and institutions who have already sold these!!!!




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.